Our History

Wilson Wolf was established in 1998 to pioneer the development of innovative mammalian cell culture devices.

We have created cell culture devices for a wide variety of applications including monoclonal antibody production, living skin, corneal storage, islet transplants for type 1 diabetes, immunotherapy, and routine cell culture.

Our Mission

Wilson Wolf creates hope for cancer patients, one device at a time. We accomplish this by way of simplifying T-cell therapy through our G-Rex platform.

Our Current Focus

  1. To provide the field of immunotherapy with the best technology for cell production. Our G-Rex® product line is quickly being adopted by the field as the gold standard.
  2. To provide those performing routine cell culture with a far superior alternative to traditional cultureware such as plates, flasks, and bags.

“The Cell Processing Lab has shown that the culture of Tumor Infiltrating Lymphocytes (TIL), Natural Killer (NK) cells and LCL cells when using the G-Rex® flasks are superior to growth bags. G-Rex® flasks allow for cell growth at higher densities and therefore less media, growth factors, cytokine and serum additives are required...”


- Clinical Center, National Institutes of Health

Wilson Wolf believes in the power of partnerships. In January 2020, we joined forces with Fresenius Kabi and Bio-Techne to form ScaleReady, a platform for the intelligent and practical scale-up of immune cell manufacturing.

ScaleReady combines our G-Rex platform for cell activation, transduction, and expansion with the cell processing and GMP reagent strengths of our partners. Together, we offer a versatile and truly scalable platform that maximizes the efficiency of cell processing, cell activation, transduction, and expansion.

Read more at the ScaleReady Website